Dr. Maria Isaac is a member of the Scientific Advice team at the European Medicines Agency (EMA) and has over 20 years of international experience in academic, clinical and regulatory fields. Her career has focused on novel and innovative pharmacological, economic and clinical treatment of mental illness.
At EMA, she has developed and maintained her interest in the clinical impact of innovative and advanced treatments with particular emphasis on dementia, biotech and stem cell therapies, not only for mental and neurological illness, though disorders of the nervous system remain her passion. She also had an active role in co-ordinating several international meetings and collaborations.
Before EMA, Maria was a Consultant Psychiatrist at the Maudsley Hospital in the UK National Health Service for more than 5 years, gaining a deep insight into the impact of mental illness on patients, their families and the wider society. As an honorary senior lecturer in psychiatry at the Institute of Psychiatry (a position she continues to hold), she built a clinical research programme and was the Co-Director of the Psychopharmacology Evaluation Unit at University Hospital Lewisham, a Unit that quickly achieved international recognition for its approach to novel pharmacological treatments of depression and the psychiatric aspects of chronic pain. A native of Spain, Maria qualified in medicine at the University of the Basque Country and obtained a Master’s degree from Temple University Philadelphia (USA). She has wide experience in molecular biology research, both in the USA (University of Pennsylvania) and UK. She trained as Psychiatrist at the Maudsley (UK). She obtained her PhD in psychopharmacology in record time at the University of London (Guy’s Hospital 1998), collecting along the way a postgraduate diploma in economics from Birkbeck College, also in the University of London. She is fluent in Spanish and English and has a good working knowledge of French and Portuguese.
Last Updated: jeudi 23 septembre 2010